当前位置: X-MOL 学术Lancet Diabetes Endocrinol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Artificial intelligence for diabetes care: current and future prospects
The Lancet Diabetes & Endocrinology ( IF 44.0 ) Pub Date : 2024-07-23 , DOI: 10.1016/s2213-8587(24)00154-2
Bin Sheng 1 , Krithi Pushpanathan 2 , Zhouyu Guan 3 , Quan Hziung Lim 4 , Zhi Wei Lim 5 , Samantha Min Er Yew 2 , Jocelyn Hui Lin Goh 6 , Yong Mong Bee 7 , Charumathi Sabanayagam 8 , Nick Sevdalis 9 , Cynthia Ciwei Lim 10 , Chwee Teck Lim 11 , Jonathan Shaw 12 , Weiping Jia 3 , Elif Ilhan Ekinci 13 , Rafael Simó 14 , Lee-Ling Lim 15 , Huating Li 3 , Yih-Chung Tham 16
Affiliation  

Artificial intelligence (AI) use in diabetes care is increasingly being explored to personalise care for people with diabetes and adapt treatments for complex presentations. However, the rapid advancement of AI also introduces challenges such as potential biases, ethical considerations, and implementation challenges in ensuring that its deployment is equitable. Ensuring inclusive and ethical developments of AI technology can empower both health-care providers and people with diabetes in managing the condition. In this Review, we explore and summarise the current and future prospects of AI across the diabetes care continuum, from enhancing screening and diagnosis to optimising treatment and predicting and managing complications.

中文翻译:


人工智能用于糖尿病护理:当前和未来前景



人们越来越多地探索人工智能 (AI) 在糖尿病护理中的应用,以便为糖尿病患者提供个性化护理,并针对复杂的情况调整治疗方法。然而,人工智能的快速发展也带来了挑战,例如潜在偏见、道德考虑以及确保其部署公平的实施挑战。确保人工智能技术的包容性和道德发展可以使医疗保健提供者和糖尿病患者能够管理病情。在这篇综述中,我们探讨并总结了人工智能在整个糖尿病护理过程中的当前和未来前景,从加强筛查和诊断到优化治疗以及预测和管理并发症。
更新日期:2024-07-23
down
wechat
bug